About Pegfilgrastim
            
            Class: | Hematopoietic growth factor (Granulocyte colony-stimulating factor)  
Use: | Used to reduce the incidence of infection, as manifested by febrile neutropenia, in patients receiving myelosuppressive chemotherapy for malignancies.  
Adult dose: | 6 mg administered as a single subcutaneous injection once per chemotherapy cycle, typically given 24 hours after chemotherapy.  
Pediatric dose: | Not established; safety and efficacy in pediatric patients have not been fully evaluated.  
Side eff
         
        
            
                
                
                    
                        Drug Class
                    
                    Hematopoietic growth factor (Granulocyte colony-stimulating factor)
                 
                
                
                    
                        Uses & Indications
                    
                    Used to reduce the incidence of infection, as manifested by febrile neutropenia, in patients receiving myelosuppressive chemotherapy for malignancies.
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. May be stored at room temperature (up to 25°C or 77°F) for up to 48 hours prior to administration.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Sandoz GmbH, AUSTRIA
                    
                    
                    Package Size
                    1 Prefilled Syringe (0.6 ml)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 3006.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        6 mg administered as a single subcutaneous injection once per chemotherapy cycle, typically given 24 hours after chemotherapy.
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; safety and efficacy in pediatric patients have not been fully evaluated.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include bone pain, fatigue, headache, nausea, and injection site reactions (e.g., redness, swelling).
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to pegfilgrastim or any component of the formulation; do not use in patients with a history of serious allergic reactions to filgrastim.
         
        
        
            
                Important Warnings
            
            Risk of splenic rupture; monitor for splenic enlargement or pain. May cause acute respiratory distress syndrome (ARDS). Use caution in patients with sickle cell disease or those at risk for sickle cell crisis.
         
        
        
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Hematopoietic growth factor (Granulocyte colony-stimulating factor) medicines available in UAE pharmacies
            
            
            
                Lenograstim
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.